Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ
Closed
Oct 23, 2026
Day's Range
302.3752 wk Range
175.89Profile - LGND - Ligand Pharmaceuticals Incorporated
Profile
Mic Code
XNMS
Sector
Healthcare
Industry
Biotechnology
Employees
47
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that focuses on developing and licensing technologies and assets that support the discovery and development of medicines. Ligand Pharmaceuticals Incorporated operates a royalty-driven business model, partnering with other biopharmaceutical companies to finance and advance late-stage clinical programs while also managing a broad portfolio of royalty interests. Its current portfolio spans commercial, clinical, and preclinical-stage assets across multiple therapeutic areas, including infectious diseases, oncology, respiratory conditions, kidney disease, and rare diseases. The company also works through technology licensing and asset acquisition activities to expand the range of medicines connected to its platform. Based in Jupiter, Florida, Ligand Pharmaceuticals Incorporated plays a specialized role in the life sciences market by providing capital, expertise, and royalty management across a diversified set of partnered drug programs.
Profile Details
Type
Common Stock
Address
555 Heritage Drive
City
Jupiter
State
FL
Zip
33458
Country
United States
Phone
858 550 7500
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
